Trian Fund Management PG trades
Nelson Peltz
Nelson Peltz Procter & Gamble Company stake
total: 34
Trades details
- Total transactions:
- 20
- New positions:
- 1
- Sold out:
- 1
- Added:
- 6
- Reduced:
- 12
- Held since:
- 2016 Q4
- Held for:
- 24 quarters
- Latest activity:
- 2022 Q4
According to 2026 Q2 report, Nelson Peltz doesn't hold any Procter & Gamble Company (PG) shares. To date, the estimated cost basis is nearly $88.82 for "buy" trades and estimated average "sell" price is $127.95. Trian Fund Management first purchased PG in 2016 Q4, initially acquiring about 6.42M shares. Since the initial investment in Procter & Gamble Company (PG), Trian Fund Management has made 19 more transactions.
When did Nelson Peltz sell Procter & Gamble Company (PG)?
Nelson Peltz sold off the entire Procter & Gamble Company (PG) position in 2022 Q4.
When did Nelson Peltz buy Procter & Gamble Company (PG)?
Nelson Peltz first invested in Procter & Gamble Company (PG) in 2016 Q4 at the reported quarter-end price of $84.08 per share.
What's the cost basis of Trian Fund Management's PG stake?
The estimated cost basis for Procter & Gamble Company (PG) stake is around $88.82 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $88.82
- Weighted AVG sell price:
- $127.95
Nelson Peltz's historical trades in Procter & Gamble Company
20 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q4
|
0.00%
|
0
|
$126.32
|
|
-100% (-5,589)
|
-0.02%
|
|
2022 Q3
|
0.02%
|
5,589
|
$126.32
|
$706,000
|
+2.42% (+132)
|
+0%
|
|
2022 Q1
|
0.01%
|
5,457
|
$163.64
|
$893,000
|
-97.70% (-231,927)
|
-0.51%
|
|
2021 Q4
|
0.52%
|
237,384
|
$163.58
|
$38,831,000
|
-95.50% (-5,032,139)
|
-10.23%
|
|
2021 Q3
|
9.16%
|
5,269,523
|
$139.80
|
$736,679,000
|
-9.02% (-522,262)
|
-0.85%
|
|
2021 Q2
|
9.14%
|
5,791,785
|
$134.93
|
$781,486,000
|
-34.81% (-3,093,092)
|
-4.94%
|
|
2021 Q1
|
14.23%
|
8,884,877
|
$135.43
|
$1,203,279,000
|
-9.56% (-938,847)
|
-1.88%
|
|
2020 Q4
|
20.23%
|
$139.14
|
-3.01% (-305,151)
|
|||
|
2020 Q3
|
23.26%
|
$138.99
|
-6.44% (-696,977)
|
|||
|
2020 Q2
|
23.41%
|
$119.57
|
-65.12% (-20,208,933)
|
|||
|
2020 Q1
|
49.20%
|
$110.00
|
-3.48% (-1,119,842)
|
|||
|
2019 Q4
|
42.34%
|
$124.90
|
-12.22% (-4,475,930)
|
|||
|
2019 Q3
|
47.56%
|
$124.38
|
+0.00% (+14)
|
|||
|
2019 Q2
|
42.39%
|
$109.65
|
-0.19% (-71,485)
|
|||
|
2019 Q1
|
40.87%
|
$104.05
|
-3.19% (-1,208,738)
|
|||
|
2018 Q4
|
37.73%
|
$91.92
|
+0.01% (+2,145)
|
|||
|
2017 Q3
|
26.56%
|
$90.98
|
+0.79% (+296,609)
|
|||
|
2017 Q2
|
24.71%
|
$87.15
|
+2.43% (+893,157)
|
|||
|
2017 Q1
|
24.74%
|
$89.85
|
+472.28% (+30,302,571)
|
|||
|
2016 Q4
|
4.86%
|
$84.08
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.